These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14526397)

  • 1. Living donor liver transplantation in patients with chronic hepatitis C: timing is everything.
    Shiffman ML
    Liver Transpl; 2003 Oct; 9(10):1036-9. PubMed ID: 14526397
    [No Abstract]   [Full Text] [Related]  

  • 2. Should living donor liver transplantation be offered to patients with hepatitis C virus cirrhosis?
    Sugawara Y; Makuuchi M
    J Hepatol; 2005 Apr; 42(4):472-5. PubMed ID: 15763329
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of adult living donor liver transplantation in patients with hepatitis C.
    Everson GT; Trotter J
    Liver Transpl; 2003 Oct; 9(10 Suppl 2):S64-8. PubMed ID: 14528432
    [No Abstract]   [Full Text] [Related]  

  • 4. The impact of advancing donor age on histologic recurrence of hepatitis C infection: the perils of ignored maternal advice.
    Charlton M
    Liver Transpl; 2003 May; 9(5):535-7. PubMed ID: 12740801
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of adult-to-adult living donor liver transplantation on access to transplantation and patients' survival: an 8-year single-center experience.
    Dumortier J; Adham M; Ber C; Boucaud C; Bouffard Y; Delafosse B; Sagnard P; Boillot O
    Liver Transpl; 2006 Dec; 12(12):1770-5. PubMed ID: 17031828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Living donor liver transplantation and hepatitis C.
    Forman LM; Trotter JF; Emond J
    Liver Transpl; 2004 Mar; 10(3):347-8. PubMed ID: 15004759
    [No Abstract]   [Full Text] [Related]  

  • 7. Liver transplantation: an update 2008.
    Said A; Lucey MR
    Curr Opin Gastroenterol; 2008 May; 24(3):339-45. PubMed ID: 18408462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.
    Takada Y; Haga H; Ito T; Nabeshima M; Ogawa K; Kasahara M; Oike F; Ueda M; Egawa H; Tanaka K
    Transplantation; 2006 Feb; 81(3):350-4. PubMed ID: 16477219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age.
    Selzner N; Girgrah N; Lilly L; Guindi M; Selzner M; Therapondos G; Adeyi O; McGilvray I; Cattral M; Greig PD; Grant D; Levy G; Renner EL
    Liver Transpl; 2008 Dec; 14(12):1778-86. PubMed ID: 19025914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Living donor liver transplantation for hepatitis C virus cirrhosis with a huge portal vein aneurysm.
    Miyazaki K; Takatsuki M; Eguchi S; Hidaka M; Tokai H; Hamasaki K; Tajima Y; Kanematsu T
    Liver Transpl; 2008 Aug; 14(8):1221-2. PubMed ID: 18668657
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of donor histology on outcome in patients undergoing transplantation for hepatitis C.
    Bahra M; Jacob D; Neumann UP; Spies F; Langrehr JM; Berg T; Neuhaus R; Neuhaus P
    Transplantation; 2007 Jul; 84(2):144-8. PubMed ID: 17667804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should we treat patients with chronic hepatitis C on the waiting list?
    Everson GT
    J Hepatol; 2005 Apr; 42(4):456-62. PubMed ID: 15763326
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular adsorbents recirculating system treatment in acute-on-chronic hepatitis patients on the transplant waiting list improves model for end-stage liver disease scores.
    Novelli G; Rossi M; Pugliese F; Poli I; Ruberto E; Martelli S; Nudo F; Morabito V; Mennini G; Berloco PB
    Transplant Proc; 2007; 39(6):1864-7. PubMed ID: 17692635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living donor liver transplantation and hepatitis C.
    Gheorghe L; Iacob S; Popescu I
    Rom J Gastroenterol; 2004 Dec; 13(4):317-27. PubMed ID: 15624030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applicability of adult-to-adult living donor liver transplantation.
    Rimola A; Llovet JM; Navasa M; Bruix J; Londoño MC; Fuster J; García-Valdecasas JC
    J Hepatol; 2005 Jul; 43(1):104-9. PubMed ID: 15876470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Estimation of indication for living donor liver transplantation in patients with HCV and/or HBV infection].
    Inoue S; Morizono S; Yamashita S; Horikawa Y; Kohjima M; Miyagi Y; Yoshimoto T; Kotoh K; Enjoji M; Takayanagi R; Soejima Y; Taketomi A; Yoshizumi T; Maehara Y; Nakamuta M
    Fukuoka Igaku Zasshi; 2007 Jul; 98(7):295-300. PubMed ID: 17710894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation.
    Shiffman ML; Stravitz RT; Contos MJ; Mills AS; Sterling RK; Luketic VA; Sanyal AJ; Cotterell A; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2004 Oct; 10(10):1248-55. PubMed ID: 15376308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Living donor liver transplantation for end-stage hepatitis C.
    Sugawara Y; Kaneko J; Akamatsu N; Kishi Y; Hata S; Kokudo N; Makuuchi M
    Transplant Proc; 2004 Jun; 36(5):1481-2. PubMed ID: 15251363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients.
    Gane E
    Liver Transpl; 2003 Nov; 9(11):S28-34. PubMed ID: 14586892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Retransplant in recurrence of hepatopathy caused by HCV].
    Bárcena R
    Gastroenterol Hepatol; 2001 Feb; 24 Suppl 1():70-4. PubMed ID: 11279898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.